Bioresorbable scaffolds & new implant devices
Vessel scaffolds that support the artery for a while and then dissolve, to avoid the permanent metal cage of drug-eluting stents — mixed record: Absorb was withdrawn, newer devices such as Firesorb and NeoVas have approvals.
1 · What it gives
Bioresorbable scaffolds (BRS) give temporary support to diseased blood vessels and then fully degrade in the body. They were introduced to overcome the limits of metallic drug-eluting stents, such as permanent caging of the vessel. The technology is at mixed stages: some early devices (Absorb) were withdrawn, while newer ones (Firesorb, NeoVas) have received regulatory approvals.
2 · What it replaces 6
3 · How to implement 3 steps
- 1PredilatePredilate with a non-compliant balloon matched to the vessel diameter.
- 2ImplantImplant the scaffold only after full balloon expansion is confirmed.
- 3Follow upFollow the device as it resorbs.
4 · Who delivers
Matched suppliers (matched automatically)
| PBS Biotech | United States | Services / consulting | active |
| Starke Ayres (Pty) Ltd. | South Africa | Research / RTO | active |
| Algal Bio | Japan | Research / RTO | active |
| FEEDMASTER (PTY) LTD | Namibia | Services / consulting | active |
| Jindalai Environmental 金达莱 (SSE 688057) | China | Research / RTO | active |
| SyncoZymes (Shanghai) | China | Producer | active |
| Abbott Laboratories | United States | Producer | active |
| Alcon | Switzerland | Producer | active |
| Boston Scientific | United States | Producer | active |
| Fresenius | Germany | Producer | active |
| GE HealthCare Technologies | United States | Producer | active |
| Johnson & Johnson | United States | Producer | active |
Leading companies and institutes (from the brief)
MicroPort (Firesorb), Lepu Medical (NeoVas), Meril Life Sciences (MeRes 100), Biotronik (Magmaris) and REVA Medical (Fantom) are named. Others are matched by the portal under Medical devices & implants.
5 · Rules & route to market
none for the service; operator permits (integrated environmental permit ~1 month)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
In China, bioresorbable scaffold devices are regulated by the NMPA.
6 · Money: tenders & grants
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 174 days |
| Grant | Strengthening forest research for the support of Ukraine European Commission · EU | Sep 22, 2027 341 days |
7 · Tech stack & innovations
Main risk from the sources: higher cost together with no clear clinical superiority over contemporary drug-eluting stents limits adoption.
Sources 5
- Microport.com.cn — www.microport.com.cn 2026-10-16
- Eurointervention.pcronline.com — eurointervention.pcronline.com 2026-10-16
- Ncbi.nlm.nih.gov — ncbi.nlm.nih.gov 2026-10-16
- Www1.hkexnews.hk — www1.hkexnews.hk 2026-10-16
- Mdpi.com — mdpi.com 2026-10-16